BDX Stock Forecast & Price Target

Becton Dickinson is a well-diversified company, with strong sales in four different business units, including a focus on the growing medical essentials and connected care sectors. Their presence in the United States and investments in high-growth markets position them for future success, while their commitment to improving public health and addressing environmental concerns adds to their positive outlook. Their projected stock price of $180 shows their potential for growth and earnings.

Becton Dickinson is a well-established player in the medical technology industry with a strong focus on innovation and addressing current public health crises. However, its heavy reliance on the US market and its relatively low expected EPS growth rate through FY2030 are cause for concern, indicating a potentially limited growth potential and profitability for the company in the long term. Additionally, while the BD Excellence initiative may drive margin expansion and revenue growth, it remains to be seen if it will be enough to offset these underlying issues.